March 26, 2024
Nippon Boehringer Ingelheim said on March 25 that it has won a sakigake fast-track designation for brigimadlin for the treatment of dedifferentiated liposarcoma. Dedifferentiated liposarcoma is a rare type of malignant tumors that commonly develop in the retroperitoneum and limbs...read more